Galmed Pharmaceuticals LTD. 6-K Filing
Ticker: GLMD · Form: 6-K · Filed: Dec 1, 2025 · CIK: 1595353
| Field | Detail |
|---|---|
| Company | Galmed Pharmaceuticals LTD. (GLMD) |
| Form Type | 6-K |
| Filed Date | Dec 1, 2025 |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
FAQ
What type of filing is this?
This is a 6-K filing submitted by Galmed Pharmaceuticals LTD. (ticker: GLMD) to the SEC on Dec 1, 2025.
How long is this filing?
Galmed Pharmaceuticals LTD.'s 6-K filing is 1 pages with approximately 188 words. Estimated reading time is 1 minutes.
Where can I view the full 6-K filing?
The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.
Filing Stats: 188 words · 1 min read · ~1 pages · Grade level 9.9 · Accepted 2025-12-01 08:38:58
Filing Documents
- form6-k.htm (6-K) — 16KB
- ex99-1.htm (EX-99.1) — 35KB
- 0001493152-25-025498.txt ( ) — 52KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Galmed Pharmaceuticals Ltd. Date: December 1, 2025 By: /s/ Allen Baharaff Allen Baharaff President and Chief Executive Officer